{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:19:36Z","timestamp":1789179576539,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006221","name":"Cordis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jcin.2012.11.006","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T17:30:18Z","timestamp":1363800618000},"page":"357-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Clinical Outcome of Patients With and Without Diabetes Mellitus After Percutaneous Coronary Intervention With the Resolute Zotarolimus-Eluting Stent"],"prefix":"10.1016","volume":"6","author":[{"given":"Sigmund","family":"Silber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian T.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz-Josef","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Belardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Widimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Novack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2012.11.006_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.104.4.491","article-title":"Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute workshop","volume":"104","author":"Grundy","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.11.006_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.11.006_bib3","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary","volume":"28","author":"Ryd\u00e9n","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2012.11.006_bib4","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.CIR.94.8.1818","article-title":"Coronary angioplasty in diabetic patients","volume":"94","author":"Kip","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.11.006_bib5","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/01.CIR.95.6.1366","article-title":"Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia","volume":"95","author":"Kornowski","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.11.006_bib6","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2012.11.006_bib7","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/CIRCULATIONAHA.105.562421","article-title":"Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial","volume":"112","author":"Sabat\u00e9","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.11.006_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.jacc.2007.07.035","article-title":"One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients","volume":"50","author":"Baumgart","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib9","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.amjcard.2008.01.040","article-title":"Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian multicenter randomized DESSERT study)","volume":"101","author":"Maresta","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib10","first-page":"886","article-title":"Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial","volume":"124","author":"Kim","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2012.11.006_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcin.2008.02.005","article-title":"Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute dynamic registry","volume":"1","author":"Mulukutla","year":"2008","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2012.11.006_bib12","first-page":"710","article-title":"A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients","volume":"78","author":"Minha","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2012.11.006_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ehj.2003.11.002","article-title":"Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients","volume":"25","author":"Abizaid","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2012.11.006_bib14","first-page":"2273","article-title":"Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy","volume":"109","author":"Moussa","year":"2004","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2012.11.006_bib15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jacc.2004.10.075","article-title":"Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial","volume":"45","author":"Hermiller","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/hrt.2005.075960","article-title":"Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes","volume":"92","author":"Hong","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2012.11.006_bib17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2007.05.038","article-title":"Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients","volume":"100","author":"Kumar","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib18","first-page":"702","article-title":"Impact of diabetes mellitus status on coronary pathoanatomy and interventional treatment: insights from the Euro Heart Survey PCI Registry","volume":"78","author":"Bauer","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2012.11.006_bib19","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/jbm.a.31664","article-title":"Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent","volume":"85A","author":"Udipi","year":"2008","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.jcin.2012.11.006_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcin.2009.07.007","article-title":"Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial","volume":"2","author":"Meredith","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2012.11.006_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2012.11.006_bib22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(11)60395-4","article-title":"Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE all comers trial","volume":"377","author":"Silber","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2012.11.006_bib23","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2011.03.005","article-title":"Clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial","volume":"57","author":"Yeung","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4244\/EIJV7I10A189","article-title":"One-year outcomes of patients with the zotarolimus-eluting coronary stent: RESOLUTE International registry","volume":"7","author":"Neumann","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2012.11.006_bib25","unstructured":"Saito S. RESOLUTE Japan 12 month results. Presented at the 20th Annual Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics in Osaka: Japan, 2011."},{"key":"10.1016\/j.jcin.2012.11.006_bib26","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jcin.2010.08.021","article-title":"Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents","volume":"3","author":"Mauri","year":"2010","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2012.11.006_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ahj.2011.03.015","article-title":"Rationale and design of the clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial)","volume":"161","author":"Mauri","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2012.11.006_bib28","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.11.006_bib29","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1161\/01.CIR.0000129767.45513.71","article-title":"Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy","volume":"109","author":"Moussa","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.11.006_bib30","first-page":"1240","article-title":"Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents","volume":"3","author":"Mauri","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib31","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.jacc.2007.01.069","article-title":"Polymer-based, paclitaxel-eluting TAXUS liberte stent in de novo lesions: the pivotal TAXUS ATLAS trial","volume":"49","author":"Turco","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4244\/EIJV7I1A15","article-title":"Platinum QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses","volume":"7","author":"Meredith","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2012.11.006_bib33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcin.2012.11.006_bib34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurheartj\/ehi138","article-title":"Guidelines for percutaneous coronary interventions: the Task Force for percutaneous coronary interventions of the European Society of Cardiology","volume":"26","author":"Silber","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2012.11.006_bib35","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2012.11.006_bib36","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa044372","article-title":"Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients","volume":"353","author":"Dibra","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2012.11.006_bib38","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jacc.2008.11.028","article-title":"A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial","volume":"53","author":"Lee","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjcard.2009.08.652","article-title":"Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus","volume":"105","author":"Zhang","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib40","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/01.ATV.0000223866.42883.3b","article-title":"Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling","volume":"26","author":"Patterson","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcin.2012.11.006_bib41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.111.031070","article-title":"Differential clinical responses to everolimus-eluting and paclitaxel-eluting coronary stents in patients with and without diabetes mellitus","volume":"124","author":"Stone","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2012.11.006_bib42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","article-title":"The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation","volume":"32","author":"Abizaid","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib43","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.amjcard.2005.07.043","article-title":"Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era","volume":"96","author":"Yang","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib44","first-page":"798","article-title":"Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial","volume":"114","author":"Fajadet","year":"2006","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2012.11.006_bib45","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2006.08.035","article-title":"Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial","volume":"48","author":"Kandzari","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jacc.2009.08.067","article-title":"A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial","volume":"55","author":"Leon","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2012.11.006_bib47","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879813003518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879813003518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:58:36Z","timestamp":1761847116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879813003518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1936879813003518"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2012.11.006","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcome of Patients With and Without Diabetes Mellitus After Percutaneous Coronary Intervention With the Resolute Zotarolimus-Eluting Stent","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2012.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}